Navigation Links
Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates
Date:1/16/2009

New Vice President Will lead Business Development and Communications for Company's International Line of Business

CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Abt Associates announced that Valerie DeFillipo, a reproductive health and rights expert, has joined the company as Vice President for Business Development and Communications for its International Line of Business. DeFillipo joins Abt Associates from the International Planned Parenthood Federation (IPPF) in London, where for the last five years she served as Director of External Affairs.

"Valerie will play a significant role in helping us grow and diversify our international development portfolio," said Abt Associates Group Vice President for International Development, Tessie San Martin. "Her experience working with a variety of international donor governments and multi-lateral agencies, as well as her expertise in policy advocacy, communications and resource mobilization strengthens our business development capability. We are delighted to have her on our team."

While at IPPF DeFillipo was a lead organizer of the Countdown 2015 Global Roundtable; a founding board member of the Safe Abortion Action Fund, a global platform funded by multiple European donor governments to reduce maternal mortality in developing countries; and led IPPF's global rebranding effort.

Prior to joining IPPF, DeFillipo enjoyed a broad and varied career with Planned Parenthood Federation of America (PPFA). While there she directed the Miami and Florida Keys affiliate, founded the international public policy arm of PPFA, and led international business development, managing family planning clinics and providing training and technical assistance support to family planning programs in the Balkans, Middle East, Asia and the Caribbean.

An accomplished presenter and media spokesperson, DeFillipo has wide experience in strategic positioning, issue advocacy and communications campaigns as well as practical experience working with a range of donor governments, multi-lateral agencies and parliamentary groups on policy formulation and resource mobilization.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; international organizations and national governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.


'/>"/>
SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
2. Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice
3. Malaysian Healthcare Industry Is in Good Shape
4. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
5. 2009 is Healthy for Asia
6. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
7. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
8. Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
9. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
10. Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference
11. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):